SIROOP Registry - a Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated with SIROlimus or Paclitaxel Eluting Balloon Catheters

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
Coronary DiseaseCoronary Artery DiseaseCoronary RestenosisCoronary ArteriosclerosisCoronary Artery CalcificationStable Chronic AnginaAngina PectorisAngina, StableAngina, UnstableStent Thrombosis
Interventions
DEVICE

Sirolimus Eluting Balloon

PTCA with either a Sirolimus eluting balloon or Paclitaxel eluting balloon

Trial Locations (1)

6000

RECRUITING

Luzerner Heart Centre, Lucerne

All Listed Sponsors
collaborator

University Hospital, Geneva

OTHER

lead

Luzerner Kantonsspital

OTHER